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ABSTRACT 
A simple, specific and economic UV spectrophotometric method has been developed using as diluents Methanol to determine the f inasteride 
content in bulk and pharmaceutical dosage formulations. The quantitative determination of the drug has been carried out at a predetermined 
λmax of 255 nm, it was proved linier in the range 2-12 μg/mL and exhibited good correlation coefficient (R2=0.999) and excellent mean 
recovery (98-99%). LOQ and LOD were found to be1.178µg/ml and 5.40µg/ml respectively. The method was validated statically and by 
recovery studies for linearity, precision, repeatability and reproducibility as per ICH guideline. The obtained results proved that the method can 
be employed for the routine analysis of finasteride in bulk as well as in the commercial formulations.  
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INTRODUCTION  
Analytical method development  
Analytical methods are planned to establish the identity, 
purity, physical characteristics and potency of the drugs and 
to support drug testing against specifications during 
manufacturing and quality release operations as well as 
during long term stability studies.  
Method validation  
Validation of an analytical method is the process by which it 
is established, by laboratory Studies, that the performance 
characteristics of the method meet the requirements for the 
Intended analytical applications. 
Finasteride chemically (5alpha, 17beta)-(1,1-
Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide. 
Finasteride is an antiandrogen which acts by inhibiting 5-
alpha reductase, the enzyme that converts testosterone to 
dihydrotestosterone.  It is used as  antiandrogen, Finasteride 
is used to shrink an enlarged prostate in adults men.Scalp 
hair loss in men.It can also be used to treat excessive hair 
growth in women and as a part of hormone therapy for 
transgender women.  
Literature survey reveals HPLC method development for the 
determination of Finasteride. . In this study, efforts were 
made to develop a simple, easy and economic UV 
spectrophotometric method using a diluents methanol for 
the determination of finasteride in raw material as well as in 
the marketed dosage formulations. The developed method 
was optimized and validated as per the guidelines of 
International Council on Hormonisation (ICH) and 
demonstrated excellent specificity, linearity, precision and 
accuracy for finasteride. 
 
Chemical structure of Finasteride 
MATERIALS AND METHODS  
Instruments  
A Shimadzu UV–visible spectrophotometer (UV1800, 
Shimadzu Corporation, Kyoto, Japan) was used for all 
absorbance measurements with matched quartz cells.  
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Materials  
All chemicals and reagents were of analytical grade. 
Finasteride in the form of powder with certificate of analysis 
was provided Arti pharmaceutical Pvt. Ltd, Mumbai.  
Determination of wavelength of maximum absorption  
A standard stock solution of Finasteride (100 μg/mL) was 
prepared using diluents to further obtain 10 μg/mL. An UV 
spectroscopic scanning (200-400 nm) was carried out with 
final diluted solution to determine λmax for the detection of 
finasteride using diluents as a blank. 
Linearity and Range  
For linearity study, six solutions at different concentrations 
(2, 4, 6, 8, 10 and 12 μg/mL) were prepared using six 
different aliquots of stock solution, and the obtained data 
were used for the linearity calibration plot. Limit of 
detection (LOD) and limit of quantification (LOQ) for the 
assay were also calculated. 
Intra-day precision (repeatability) and inter-day 
precision study (intermediate precision)  
Finasteride 100 μg/mL was prepared following the same 
dilution pattern of stock solution. Three different aliquots of 
stock solution were then diluted to 10 mL to obtain the 
concentrations of 4, 8 and 12μg/mL. This procedure was 
repeated in the different days. 
Stability study  
Samples prepared for repeatability study were preserved for 
24 h at room temperature and analyzed on the following day 
to test for short-term stability. 
Accuracy/recovery study  
This study was carried out using tablet of Finasteride. 
Calculation was done from the label claim and the average 
weight of the final product. Previously used dilution pattern 
was followed for the tablet to obtain three concentrations—
80%, 100% and 120% of reference solution. 
Specificity in the presence of excipients  
The test for the specificity was carried out using only 
excipients. Spectra for placebo tablet, blank, and sample 
were compared. Secondly the specificity was determined by 
subjecting the sample solution to accelerated degradation by 
heat (60 °C) for 48 h in order to verify that none of the 
degradation products interfered with the quantification of 
the drug.  
Assay of content of Finasteride in selected marketed 
brands  
Market brands of Finasteride tablet from different 
manufacturers were randomly selected and analyzed using 
the newly developed and validated method. Sample 
solutions of brand (10 mg/mL) were also prepared and 
assayed for content of finasteride against the standard. The 
content of finasteride in the marketed brands was 
determined using standard calculations. 
Stress Degradation Studies 
 Acid degradation 
The preparation of 0.01N hydrochloric acid (HCl) was done 
by diluting 0.085 ml of conc. HCl to 100 ml of distilled water 
was accurately weighted and was transferred to a labeled 
round bottomed flask. Take 10mg of drug and add 5ml of 
methanol makeup upto 10ml with 0.01N HCL. Reflux the 
sample for 2 hrs. And pipette out 1ml to10 ml volumetric 
flask. Make the final dilution so as to get final concentration 
10ppm. Take the reading on UV. Check the degradation 
behavior of drug. 
Base degradation:  
The 0.01N Sodium Hydroxide (NaOH) was prepared by 
dissolving 0.04 gm of sodium hydroxide pellets in 100 ml of 
distilled water. The solution was standardized with 0.01 N 
HCl as per Indian Pharmacopoeia (I.P).  
Finasteride was accurately weighted and was transferred to 
a labeled round bottomed flask. . Take 10mg of drug and add 
5ml of methanol makeup up to 10ml with 0.01N NAOH. 
Reflux the sample for 2 hrs. And pipette out 1ml to 10 ml 
volumetric flask and adjust with mobile phase. Make the 
final dilution so as to get final concentration 10 ppm. Take 
the reading on UV. Check the degradation behavior of drug. 
Neutral condition:  
Weight accurately 10 mg drug and transferred in to100 ml 
water in round bottom flask. Take 10mg of drug and add 5ml 
of methanol makeup up to 10ml with distil water. Reflux it 
for 2 hours. Pipette out 1ml in to 10 ml volumetric flask and 
adjust with mobile phase. As well as also prepare the 
10μg/ml sample solution. Take the reading on UV. Check the 
degradation behavior of drug. 
Photo stability study:  
Photo stability was performed by placing 10 mg of 
Finasteride in daylight for 8 -12 hours. The samples were 
diluted with methanol up to 10ml in a volumetric flask. 
Pipette out 1ml sample diluted up to 10 ml by mobile phase 
As well as also prepare the 10μg/ml sample solution. Take 
the reading on UV. Check the degradation behavior of drug. 
 Dry heat:  
Standard Finasteride was placed in an oven at 600ºC for 2 
hours to study dry heat degradation. 10 mg drug samples 
were diluted with methanol up to 10ml in a volumetric flask. 
Pipette out 1 ml and were diluted up to 10 ml by mobile 
phase. As well as also prepare the10 μg/ml sample solution. 
Take the reading on UV. Check the degradation behavior of 
drug.  
 Oxidation Study  
Weight accurately 10 mg drug and transferred in 100 ml 
round bottom flask and added 3% w/v hydrogen peroxide. 
Keep it at dark place for 2 hours. Pipette out 1ml in to 10 ml 
volumetric flask and adjust with mobile phase. As well as 
also prepare the 10μg/ml sample solution. Take the reading 
on UV. Check the degradation behavior of drug. 
RESULTS AND DISCUSSION  
Method development and optimization  
An accurately weighed quantity of finasteride (10 mg) 
transferred into a 100 ml volumetric flasks, dissolved well 
and diluted to the mark with Methanol to obtain standard 
solution having concentration of (100 µg/ml). A 1 ml of 
solution transferred into a 10 ml volumetric flasks and 
diluted to the mark with finasteride to obtain the solutions 
having the concentrations of 10µg/ml for finasteride. The 
pre-determined wavelength of maximum absorption (λmax) 
was 255 nm. (Fig. 2) 
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Figure 2: UV Spectrum of Finasteride 
Method validation  
Linearity and range  
The calibration curve obtained was evaluated by its 
correlation coefficient. The absorbance of the samples in the 
range of 2.0–12.0 mg/mL was linear with a correlation 
coefficient (R2) was obtained 0.999 (Table 1). The LOD and 
LOQ were calculated as 1.178µg/ml and 5.40µg/ml 
respectively. 
Table 1: Linearity data 
Concentration  μg/ml Absorbance 
2 0.074 
4 0.177 
6 0.282 
8 0.425 
10 0.483 
12 0.585 
 
Intra-day and inter-day precision  
The intra-day and inter-day precision study (Table 2) of the 
developed method confirmed adequate sample stability and 
method reliability where all the RSDs were less than 2%. 
Stress Degradation Studies 
Stability studies results were studied as stress degradation 
studies (Table 3) of the developed method to confirmed and 
checked adequate sample stability in different conditions.
 
Table 2: Intra-day and inter-day precision determined for three different concentrations of Finasteride (n=6). 
Conc.μg/mL Intra-day precision Inter-day precision 
Absorbance 
measured 
RSD (%) Absorbance 
measured 
RSD (%) 
4 0.03533 1.4605154 0.032167 1.1595 
8 0.04716 0.8651 0.04483 0.8310 
12 0.08083 0.504 0.070667 1.33200 
 
Table 3: Short term stability determined by the proposed method 
Sr. No Stress condition Degradation % Remark 
1 Photolytic  47.34 Unstable 
2 Thermal  50.60 Unstable 
3 0.01N HCl 40.90 Unstable 
4 0.01N NaOH 49.90 Unstable 
5 H2O2 52.95 Unstable 
6. Neutral 37.39 Unstable 
 
CONCLUSION  
The results and the statistical parameters demonstrate that 
the proposed UV spectrophotometric method is simple, 
rapid, specific, accurate and precise. Therefore, this method 
can be used for the determination of finasteride either in 
bulk or in the dosage formulations without interference with 
commonly used excipients and related substances. 
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